Composite Lymphoma: Opposite Ends of Spectrum Meet. uri icon

Overview

abstract

  • An 18-year-old African-American female presented with an episode of syncope. Initial investigations revealed large lung mass with invasion into right atrium along with lesions in kidneys and liver. Patient also developed superior vena cava syndrome due to lung mass. Biopsy of lung mass revealed diagnosis of composite lymphoma with involvement by primary mediastinal B-cell lymphoma (PMBCL) and classical Hodgkin lymphoma. Patient was started on dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH-R) with complete response to treatment. This case represents an extremely rare type of aggressive lymphoma and can guide clinicians in managing such cases since there are no standard guidelines for treatment. To the best of our knowledge, this is the first reported case of composite lymphoma of PMBCL and classical Hodgkin lymphoma successfully treated with dose-adjusted EPOCH-R regimen.

publication date

  • January 25, 2017

Identity

PubMed Central ID

  • PMC5289141

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1214561

PubMed ID

  • 28179969

Additional Document Info

volume

  • 9

issue

  • 3